Ht-Supreme Drug Coated Coronary Stent System

Still deciding? Get samples of $ !
Request Sample

Product Description

Basic Information

Model NO.
HT-SUPREME
Group
Adult
Logo Printing
Without Logo Printing
Base Layer
2.0f Proximal, 2.5f Distal
Usable Length
Eg Coating
Polymer Material
Plga
Drug Dose
Sirolimus 1.2 µg / mm²
Delivery System Length
145 Cm
Transport Package
Box
Specification
Individual package
HS Code
90183990

Product Description

Advanced Coating System | Safe Clinical Data | Superior Deliverability

The Healing-Targeted Drug Eluting Stent is designed specifically to allow natural healing through elution kinetics, biodegradable polymer and specialized coating. This new class of DES focused on rapid healing allows a quicker return of the protective endothelial layer.

Product Features

Better and faster return of healing

The HT Supreme® Drug Eluting Stent dose and kinetics were engineered to for a better and faster return of healing with 90% of drug released within 28 days.

Drug Eluting Stent Healing Kinetics

Stronger coating integrity and more consistent results

Through a patented electro-chemical process, eG™ coating is synthesized onto the surface of the stent, creating a filament-like structure that interdigitates into the matrix polymer layer. This technique creates a robust coating integrity that is resistant to flaking, pealing and cracking.

Stent and delivery system designed for excellent deliverability

The thin-strut design and delivery system improvements allow for better trackability and pushability after multiple uses. The inner-shaft design also allows for smother device pull-back.

Delivery System Design

Product Parameters

Compliance Chart

Compliance Chart

Product Specifications

Product Specifications Table

Ordering Information

Ordering Information Table

Frequently Asked Questions

What is the HT-SUPREME Drug Eluting Stent?
It is a healing-targeted stent designed to allow natural vessel healing through specialized elution kinetics and a biodegradable polymer coating.
How fast is the drug released?
The stent is engineered for rapid drug release, with 90% of the drug released within 28 days to encourage faster endothelial healing.
What makes the coating integrity superior?
It uses a patented electro-chemical eG™ coating process that creates a filament-like structure resistant to flaking, peeling, and cracking.
How does the delivery system improve performance?
The system features a thin-strut design and an improved inner-shaft for better trackability, pushability, and smoother device pull-back.
What is the drug dose used on the stent?
The stent is coated with Sirolimus at a dose of 1.2 µg / mm² for effective restenosis prevention.
Is the polymer used biodegradable?
Yes, the stent utilizes a PLGA biodegradable polymer to facilitate the drug delivery and subsequent healing process.

Related Products